Combination of medicinal herbs KIOM-79 reduces advanced glycation end product accumulation and the expression of inflammatory factors in the aorta of zucker diabetic fatty rats

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Sohn, Eunjin ^a   Kim, Junghyun ^a   Jeong, Il Ha ^a   Kim, Chan Sik ^a   Kim, Young Sook ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KIOM 79; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISSECTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GEL MOBILITY SHIFT ASSAY; HERB; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAGE; RAT; VASCULAR DISEASE; VASCULITIS; ZUCKER DIABETIC FATTY RAT;

EID: 79953324776     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/784136     Document Type: Article

References (40)

1. Erdmann E., Diabetes and cardiovascular risk markers Current Medical Research and Opinion, Supplement 2005 21 1 S21 S28
2. Renard C., Van Obberghen E., Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes and Metabolism 2006 32 1 15 29 (Pubitemid 43872592)
3. Basta G., Schmidt A. M., De Caterina R., Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovascular Research 2004 63 4 582 592 (Pubitemid 39078671)
4. Figarola J. L., Shanmugam N., Natarajan R., Rahbar S., Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes Diabetes 2007 56 3 647 655 (Pubitemid 46348459)
5. Thornalley P. J., Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Archives of Biochemistry and Biophysics 2003 419 1 31 40 (Pubitemid 37279141)
6. Guo Z. J., Niu H. X., Hou F. F., Zhang LU., Fu N., Nagai R., Lu X., Chen B. H., Shan Y. X., Tian J. W., Nagaraj R. H., Xie DI., Zhang X., Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway Antioxidants and Redox Signaling 2008 10 10 1699 1712
7. Yamagishi S. I., Nakamura K., Matsui T., Ueda S., Fukami K., Okuda S., Agent that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications Expert Opinion on Investigational Drugs 2008 17 7 983 996
8. Alarcon-Aguilara F. J., Roman-Ramos R., Perez-Gutierrez S., Aguilar-Contreras A., Contreras-Weber C. C., Flores-Saenz J. L., Study of the anti-hyperglycemic effect of plants used as antidiabetics Journal of Ethnopharmacology 1998 61 2 101 110 (Pubitemid 28297899)
9. Aida K., Tawata M., Shindo H., Onaya T., Sasaki H., Yamaguchi T., Chin M., Mitsuhasi H., Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix Planta Medica 1990 56 3 254 258 (Pubitemid 20244016)
10. Kang K. A., Chae S., Koh Y. S., Kim J. S., Lee J. H., You HO. J., Hyun J. W., Protective effect of Puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin Biological and Pharmaceutical Bulletin 2005 28 7 1154 1160 (Pubitemid 41327577)
11. Hur J., Donguibogam Paralled Version. Committee of Dongui Bogam Translation 1999 Seoul, Korea Bupin
12. Kim J. S., Kim H. J., Ko J. H., Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the formation of advanced glycation endproducts(AGEs) in vitro of unprocessed- and processed Magnolia Bark Korean Journal of Pharmacognosy 2002 33 4 308 311 (Pubitemid 36091109)
13. Kim Y. S., Jung D. H., Kim N. H., Lee Y. M., Jang D. S., Song G. Y., Kim J. S., KIOM-79 inhibits high glucose or AGEs-induced VEGF expression in human retinal pigment epithelial cells Journal of Ethnopharmacology 2007 112 1 166 172 (Pubitemid 46702431)
14. Kim Y. S., Lee Y. M., Kim C. S., Sohn E. J., Jang D. S., Kim J. S., Inhibitory effect of KIOM-79, a new herbal prescription, on AGEs formation and expressions of type IV collagen and TGF- 1 in STZ-induced diabetic rats Korean Journal of Pharmacognosy 2006 37 2 103 109 (Pubitemid 44048802)
15. Kim C. S., Sohn E. J., Kim Y. S., Jung D. H., Jang D. S., Lee Y. M., Kim D. H., Kim J. S., Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats Journal of Ethnopharmacology 2007 111 2 240 247 (Pubitemid 46528078)
16. Jeon Y. J., Li M. H., Lee K. Y., Kim J. S., You HO. J., Lee S. K., Sohn H. M., Choi S. J., Koh J. W., Chang IN. Y., KIOM-79 inhibits LPS-induced iNOS gene expression by blocking NF- B/Rel and p38 kinase activation in murine macrophages Journal of Ethnopharmacology 2006 108 1 38 45 (Pubitemid 44498987)
17. Kang K. A., Kim J. S., Zhang R., Piao M. J., Ko D. O., Wang Z. H., Maeng Y. H., Eun SU. Y., Hyun J. W., "Induction of heme oxygenase-1 by plant extract KIOM-79 via Akt pathway and NF-E2 related factor 2 in pancreatic β-cells" Journal of Toxicology and Environmental Health A 2008 71 20 1392 1399
18. Koji T., Komuta K., Nozawa M., Yamada S., Nakane P. K., Localization of cyclic adenosine 3′, 5′ -monophosphate-responsive element (CRE)-binding proteins by Southwestern histochemistry Journal of Histochemistry and Cytochemistry 1994 42 10 1399 1405 (Pubitemid 24307731)
19. Schmidt A. M., Yan S. D., Wautier J. L., Stern D., Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circulation Research 1999 84 5 489 497 (Pubitemid 29138585)
20. Rahman S., Rahman T., Ismail A. A. S., Rashid A. R. A., Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis Diabetes, Obesity and Metabolism 2007 9 6 767 780 (Pubitemid 47555200)
21. Sohn E. J., Kim Y. S., Kim C. S., Lee Y. M., Kim J. S., KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice Journal of Ethnopharmacology 2009 121 1 171 174
22. Kim Y. S., Kim J., Kim C. S., KIOM-79, an inhibitor of AGEs-protein cross-linking, prevents progression of nephropathy in Zucker diabetic fatty rats. Evidence-Based Complementary and Alternative Medicine. In press
23. Oltman C. L., Richou L. L., Davidson E. P., Coppey L. J., Lund D. D., Yorek M. A., Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats American Journal of Physiology 2006 291 4 H1780 H1787
24. Degenhardt T. P., Alderson N. L., Arrington D. D., Beattie R. J., Basgen J. M., Steffes M. W., Thorpe S. R., Baynes J. W., Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney International 2002 61 3 939 950 (Pubitemid 34175462)
25. Gao X., Zhang H., Schmidt A. M., Zhang C., AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice American Journal of Physiology 2008 295 2 H491 H498
26. Boileau T. W.-M., Bray T. M., Bomser J. A., Ultraviolet radiation modulates nuclear factor kappa B activation in human lens epithelial cells Journal of Biochemical and Molecular Toxicology 2003 17 2 108 113 (Pubitemid 36575814)
27. Baeuerle P. A., Henkel T., Function and activation of NF- B in the immune system Annual Review of Immunology 1994 12 141 179
28. Khan Z. A., Chakrabarti S., Cellular signaling and potential new treatment targets in diabetic retinopathy Experimental Diabetes Research 2007 2007 12
29. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A., Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 2006 114 6 597 605 (Pubitemid 44199649)
30. Nakamura K., Yamagishi S. I., Adachi H., Matsui T., Kurita-Nakamura Y., Takeuchi M., Inoue H., Imaizumi T., Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes Microvascular Research 2008 76 1 52 56
31. Isoda K., Folco E., Marwali M. R., Ohsuzu F., Libby P., Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis Atherosclerosis 2008 198 2 307 312
32. Renier G., Mamputu J. C., Serri O., Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells Metabolism 2003 52 8 13 18 (Pubitemid 37098384)
33. Jackson J. R., Seed M. P., Kircher C. H., Willoughby D. A., Winkler J. D., The codependence of angiogenesis and chronic inflammation FASEB Journal 1997 11 6 457 465 (Pubitemid 27259987)
34. Lu M., Kuroki M., Amano S., Tolentino M., Keough K., Kim I., Bucala R., Adamis A. P., Advanced glycation end products increase retinal vascular endothelial growth factor expression Journal of Clinical Investigation 1998 101 6 1219 1224 (Pubitemid 28145237)
35. Huang S., Robinson J. B., DeGuzman A., Bucana C. D., Fidler I. J., Blockade of nuclear factor- b signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8 Cancer Research 2000 60 19 5334 5339
36. Fujioka S., Niu J., Schmidt C., Sclabas G. M., Peng B., Uwagawa T., Li Z., Evans D. B., Abbruzzese J. L., Chiao P. J., NF- B and AP-1 connection: mechanism of NF- B-dependent regulation of AP-1 activity Molecular and Cellular Biology 2004 24 17 7806 7819 (Pubitemid 39121503)
37. Hattori Y., Banba N., Gross S. S., Kasai K., Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor B-dependent transcriptional activation of inducible nitric oxide synthase Biochemical and Biophysical Research Communications 1999 259 1 128 132 (Pubitemid 29264005)
38. Kawaguchi M., Koshimura K., Sohmiya M., Murakami Y., Gonda T., Kato Y., Effect of insulin on nitric oxide synthase-like immunostaining of arteries in various organs in Zucker diabetic fatty rats European Journal of Endocrinology 2001 145 3 343 349 (Pubitemid 32825668)
39. Hasan K., Heesen B. J., Corbett J. A., McDaniel M. L., Chang K., Allison W., Wolffenbuttel B. H. R., Williamson J. R., Tilton R. G., Inhibition of nitric oxide formation by guanidines European Journal of Pharmacology 1993 249 1 101 106 (Pubitemid 23326915)
40. Menzel E. J., Neumller J., Sengoelge G., Reihsner R., Effects of aminoguanidine on adhesion molecule expression of human endothelial cells Pharmacology 1997 55 3 126 135 (Pubitemid 27417420)